⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8186830 | 0.86 | — | — | |
| SCHEMBL161507 | 0.71 | — | — | |
| SCHEMBL1340249 | 0.67 | — | — | |
| SCHEMBL6738847 | 0.67 | TYR (0.39) | — | |
| SCHEMBL112009 | 0.67 | — | — | |
| SCHEMBL12135406 | 0.67 | — | — | |
| SCHEMBL15903263 | 0.67 | — | — | |
| SCHEMBL10455224 | 0.67 | — | — | |
| SCHEMBL10385817 | 0.66 | GAA (0.36) | — | |
| SCHEMBL10986390 | 0.66 | ALDH1A1 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1673321-B9 | METHOD OF PREPARING FULVENE COMPOUNDS AND METHOD OF PREPARING ANSA-METALLOCENE COMPOUNDS USING THE COMPOUNDS | LG CHEMICAL LTD (KR) | 2015-04-22 | — | — | EP | claimed |
| EP-1673321-B1 | METHOD OF PREPARING FULVENE COMPOUNDS AND METHOD OF PREPARING ANSA-METALLOCENE COMPOUNDS USING THE COMPOUNDS | LG CHEMICAL LTD (KR) | 2014-09-17 | — | — | EP | claimed |
| US-7166731-B2 | Method of preparing fulvene compounds and method of preparing ansa-metallocene compounds using the compounds | LG CHEM. LTD. (KR) | 2007-01-23 | — | — | US | claimed |
| US-20050080296-A1 | Method of preparing fulvene compounds and method of preparing ansa-metallocene compounds using the compounds | LG CHEM. LTD. (KR) | 2005-04-14 | — | — | US | claimed |
| US-20250178997-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-06-05 | — | — | US | disclosed |
| EP-4490139-A1 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2025-01-15 | — | — | EP | disclosed |
| CN-118786110-A | Organic compound | 奇华顿股份有限公司 | 2024-10-15 | — | — | CN | disclosed |
| WO-2023170192-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2023-09-14 | — | — | WO | disclosed |
| WO-2022150667-A1 | NIMBOLIDE ANALOGS AND METHODS OF USE THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-07-14 | — | — | WO | disclosed |
| EP-3194418-B1 | SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF | PREVACUS INC (US) | 2021-12-15 | — | — | EP | disclosed |
| EP-3194418-A1 | SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF | Prevacus Inc. (US) | 2017-07-26 | — | — | EP | disclosed |
| US-20160108081-A1 | SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF | PREVACUS INC (US) | 2016-04-21 | — | — | US | disclosed |
| US-20160108081-A1 | SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF | PREVACUS INC (US) | 2016-04-21 | — | — | US | disclosed |
| US-20160108081-A1 | SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF | PREVACUS INC (US) | 2016-04-21 | — | — | US | disclosed |
| WO-2016044558-A1 | SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF | PREVACUS, INC. (US) | 2016-03-24 | — | — | WO | disclosed |
| EP-1673321-B9 | METHOD OF PREPARING FULVENE COMPOUNDS AND METHOD OF PREPARING ANSA-METALLOCENE COMPOUNDS USING THE COMPOUNDS | LG CHEMICAL LTD (KR) | 2015-04-22 | — | — | EP | disclosed |
| EP-1673321-B1 | METHOD OF PREPARING FULVENE COMPOUNDS AND METHOD OF PREPARING ANSA-METALLOCENE COMPOUNDS USING THE COMPOUNDS | LG CHEMICAL LTD (KR) | 2014-09-17 | — | — | EP | disclosed |
| US-7166731-B2 | Method of preparing fulvene compounds and method of preparing ansa-metallocene compounds using the compounds | LG CHEM. LTD. (KR) | 2007-01-23 | — | — | US | disclosed |
| US-20050080296-A1 | Method of preparing fulvene compounds and method of preparing ansa-metallocene compounds using the compounds | LG CHEM. LTD. (KR) | 2005-04-14 | — | — | US | disclosed |